Final answer:
Magnesium deficiency is associated with insulin resistance, contributing to metabolic dysfunction. Low magnesium acts as a risk factor by impairing glucose and insulin metabolism and inducing associated disorders. Adequate magnesium intake or supplementation can help improve insulin sensitivity and metabolic profiles.
Step-by-step explanation:
A mineral deficiency that is associated with insulin resistance is magnesium deficiency. Research indicates that low levels of magnesium can contribute to insulin resistance and have metabolic implications. For instance, magnesium is vital for glucose and insulin metabolism as it acts as a cofactor for several enzymes involved in these processes. Insulin resistance can arise when there is inadequate magnesium to support these metabolic pathways. The relationship between magnesium deficiency and insulin resistance is supported by studies showing that obese children and adults with insulin resistance often have lowered magnesium levels. Moreover, experimental models of low magnesium intake in animals lead to increased insulin resistance, hypertension, and changes in lipid metabolism.
Chronic magnesium deprivation can also lead to increased glucocorticoid exposure, which may exacerbate insulin resistance and associated metabolic disorders. Conversely, magnesium supplementation has been shown to improve insulin sensitivity, reduce inflammatory markers, and help maintain better glucose and lipid profiles. In the context of insulin resistance, adequate magnesium intake appears to be protective against the development of metabolic complications, highlighting its importance in dietary management and potential therapeutic approaches for addressing insulin resistance.